HLA-C and neoplasm: Tumor-specific antigens can be presented as peptides on the tumor cell surface in major histocompatibility complex (MHC) proteins, which interact with the T-cell receptors (TCR) on antigen-specific T cells to stimulate an anti-tumor response.